Format

Send to

Choose Destination
J Biopharm Stat. 2015;25(6):1285-311. doi: 10.1080/10543406.2014.1000546. Epub 2015 Jan 28.

Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.

Author information

1
a National Center for Tumor Diseases Heidelberg , Heidelberg , Germany.
2
b Institute of Medical Biometry and Informatics, University of Heidelberg , Heidelberg , Germany.

Abstract

This article deals with seven special issues related to the assumptions, applicability, and practical use of formulas for calculating power or sample size, respectively, for comparative clinical trials with time-to-event endpoints, with particular focus on the well-known Freedman and Schoenfeld methods. All problems addressed are illustrated by numerical examples, and recommendations are given on how to deal with them in the planning of clinical trials.

KEYWORDS:

Controlled clinical trial; Freedman formula; Sample size; Schoenfeld formula; Time-to-event data

PMID:
25629760
DOI:
10.1080/10543406.2014.1000546
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center